Early Versus Late Catheter Removal in Patients With Acute Urinary Retention Secondary to BPH Under Tamsulosin Treatment
1 other identifier
interventional
60
1 country
1
Brief Summary
The aim of this work is to compare between early (3days) and late(7days) removal of urinary catheter after acute urine retention in patients with Benign Prostatic Hyperplasia under Tamsulosin treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 12, 2017
CompletedFirst Submitted
Initial submission to the registry
August 12, 2017
CompletedFirst Posted
Study publicly available on registry
September 12, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 16, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
September 16, 2017
CompletedSeptember 25, 2017
September 1, 2017
6 months
August 12, 2017
September 20, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The duration for trial without catheter
To determine the optimum period to remove catheter in patients complaining of acute urinary retention with benign prostatic hyperplasia.
6 Months
Secondary Outcomes (1)
Factor affecting trial without catheter
6 Months
Study Arms (2)
early catheter removal
ACTIVE COMPARATOR30 patients will receive Tamsulosin hydrochloride 0.4 mg once daily and the catheter will be removed after 3 days.
late catheter removal
ACTIVE COMPARATOR30 patients will receive Tamsulosin hydrochloride 0.4 mg once daily and the catheter will be removed after 7 days.
Interventions
Patients will receive selective alpha blocker ( tamsulosin 0.4mg ) once daily and the catheter will be removed after 3 days. After catheter removal, patients will be allowed to void and will be discharged home who will have a successful void more than 200 cc of urine. Patients who will fail to void will be re-catheterized and will be prepared for prostatectomy.
Patients will receive selective alpha blocker ( tamsulosin 0.4mg ) once daily and the catheter will be removed after 7 days. After catheter removal, patients will be allowed to void and will be discharged home who will have a successful void more than 200 cc of urine. Patients who will fail to void will be re-catheterized and will be prepared for prostatectomy.
Eligibility Criteria
You may qualify if:
- Patients having first attack of acute urinary retention secondary to BPH.
You may not qualify if:
- Renal impairment.
- Suspected urethral stricture.
- Neurogenic bladder.
- Cancer prostate.
- Medically induced retention.
- Previous use of alpha blockers.
- History of drug hypersensitivity or allergy to Tamsulosin.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculty of medicine ,Al Azhar university
Cairo, El Mokhayam El Daem St.، Ezbet El-Arab, Nasr City, Cairo, Egypt
Study Officials
- STUDY CHAIR
Mohamed M Badr, PHD
Al-Azhar University
- STUDY DIRECTOR
Mohamed F El Saeed El Ebiary, MD
Al-Azhar University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Cairo, Egypt
Study Record Dates
First Submitted
August 12, 2017
First Posted
September 12, 2017
Study Start
March 12, 2017
Primary Completion
September 16, 2017
Study Completion
September 16, 2017
Last Updated
September 25, 2017
Record last verified: 2017-09
Data Sharing
- IPD Sharing
- Will not share